X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (205) 205
humans (182) 182
modified recist (141) 141
female (123) 123
male (123) 123
middle aged (118) 118
oncology (111) 111
aged (105) 105
hepatocellular carcinoma (91) 91
cancer (88) 88
treatment outcome (85) 85
adult (78) 78
care and treatment (58) 58
liver neoplasms - therapy (58) 58
solid tumors (58) 58
transarterial chemoembolization (58) 58
sorafenib (57) 57
survival (56) 56
carcinoma, hepatocellular - therapy (55) 55
radiology, nuclear medicine & medical imaging (55) 55
liver neoplasms - pathology (53) 53
carcinoma, hepatocellular - pathology (52) 52
aged, 80 and over (50) 50
prognosis (50) 50
retrospective studies (49) 49
gastroenterology & hepatology (47) 47
liver cancer (45) 45
hepatoma (43) 43
chemotherapy (42) 42
tumors (41) 41
liver (40) 40
medicine & public health (40) 40
tumor response (38) 38
liver neoplasms - diagnostic imaging (37) 37
carcinoma, hepatocellular - diagnostic imaging (35) 35
chemoembolization, therapeutic - methods (34) 34
liver neoplasms - drug therapy (33) 33
therapy (33) 33
tomography, x-ray computed (33) 33
management (32) 32
neoplasm staging (32) 32
analysis (30) 30
carcinoma, hepatocellular - drug therapy (30) 30
criteria (30) 30
genetically modified organisms (29) 29
transcatheter arterial chemoembolization (29) 29
liver neoplasms - mortality (28) 28
metastasis (28) 28
disease-free survival (27) 27
survival rate (27) 27
patients (26) 26
recist (26) 26
antineoplastic combined chemotherapy protocols - therapeutic use (25) 25
carcinoma, hepatocellular - mortality (25) 25
research (25) 25
evaluation criteria (24) 24
immunotherapy (24) 24
response evaluation criteria (24) 24
magnetic resonance imaging (23) 23
mrecist (23) 23
antineoplastic agents - therapeutic use (22) 22
easl (21) 21
modified recist mrecist (21) 21
article (20) 20
cancer research (20) 20
hepatocellular-carcinoma (20) 20
niacinamide - analogs & derivatives (20) 20
phase-ii (19) 19
response evaluation criteria in solid tumors (19) 19
young adult (19) 19
antimitotic agents (18) 18
antineoplastic agents (18) 18
chemoembolization, therapeutic (18) 18
clinical trials (18) 18
drug therapy (18) 18
tace (18) 18
cancer therapies (17) 17
chemoembolization (17) 17
drug-eluting beads (17) 17
hematology, oncology and palliative medicine (17) 17
medical research (17) 17
phenylurea compounds - therapeutic use (17) 17
prospective studies (17) 17
carcinoma (16) 16
computed-tomography (16) 16
contrast media (16) 16
development and progression (16) 16
hcc (16) 16
immunology (16) 16
kaplan-meier estimate (16) 16
antineoplastic agents - administration & dosage (15) 15
biomarkers (15) 15
computed tomography (15) 15
follow-up studies (15) 15
health aspects (15) 15
liver transplantation (15) 15
niacinamide - therapeutic use (15) 15
radiology (15) 15
studies (15) 15
t cells (15) 15
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Thoracic Oncology, ISSN 1556-0864, 03/2011, Volume 6, Issue 3, pp. 598 - 601
Journal Article
Journal Article
肝臓, ISSN 0451-4203, 2011, Volume 52, Issue 5, pp. 322 - 324
RECIST, mRECIST and RECICL are criteria for evaluating the therapeutic response of hepatocellular carcinoma and there are several differences among these... 
ソラフェニブ | 肝細胞癌 | mRECIST
Journal Article
European Journal of Gastroenterology & Hepatology, ISSN 0954-691X, 11/2012, Volume 24, Issue 11, pp. 1325 - 1332
Journal Article
European Radiology, ISSN 0938-7994, 8/2015, Volume 25, Issue 8, pp. 2502 - 2511
Journal Article
Journal Article
肝臓, ISSN 0451-4203, 2012, Volume 53, Issue 3, pp. 147 - 154
2010年にLencioniらによって提唱されたmodified... 
分子標的治療 | sorafenib | 肝細胞癌 | modified RECIST | 血流評価
Journal Article
Journal of Vascular and Interventional Radiology, ISSN 1051-0443, 2012, Volume 23, Issue 12, pp. 1629 - 1637
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 08/2016, Volume 34, Issue 23, pp. 2797 - 2797
Journal Article
by Kim, JH
JOURNAL OF THORACIC ONCOLOGY, ISSN 1556-0864, 01/2017, Volume 12, Issue 1, pp. S1472 - S1472
Conference Proceeding
Journal Article
Journal of Cancer, ISSN 1837-9664, 2015, Volume 6, Issue 2, pp. 169 - 176
Background: The RECIST 1.1 adopted a total of five target lesions to be measured, with a maximum of two lesions per organ. To the best of our knowledge, the... 
RECIST 1.1 | Modified RECIST 1.1 | Target lesion | Tumor response | Single-lesion measurement | NUMBER | SOLID TUMORS | TARGET LESIONS | GUIDELINE VERSION 1.1 | RECIST CRITERIA | COMPUTED-TOMOGRAPHY | modified RECIST 1.1 | TYROSINE KINASE INHIBITORS | CELL LUNG-CANCER | VARIABILITY | ONCOLOGY | ADVANCED GASTRIC-CANCER
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 10/2013, Volume 31, Issue 28, pp. 3517 - 3524
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.